肝移植前慢加急性肝衰竭患者的病情稳定可预测移植后生存
该回顾性研究分析了2009至2014年间本机构250例首次肝移植的肝硬化患者,其中98例在移植前3个月内符合慢加急性肝衰竭诊断标准。与非慢加急性肝衰竭患者相比,慢加急性肝衰竭与移植后短期发病率和死亡率显著升高相关(90天患者生存率96.1% vs 72.4%,P<0.0001)。移植前临床改善(至少一个先前衰竭器官系统恢复)见于98例慢加急性肝衰竭患者中的37例,且与接近非慢加急性肝衰竭受者的良好移植后生存率相关。
要点
- 慢加急性肝衰竭患者移植后90天生存率72.4%,非慢加急性肝衰竭患者为96.1%(P<0.0001)。
- 98例慢加急性肝衰竭患者中37例在移植前出现临床改善,多发生于诊断后数日内。
- 移植前临床改善的慢加急性肝衰竭患者移植后生存率接近非慢加急性肝衰竭受者。
核心结论
- 慢加急性肝衰竭预示原位肝移植后不良结局。
- 鉴于不移植的预后极差,研究结果表明慢加急性肝衰竭患者可接受移植且结局相对良好,尤其是保守治疗下病情改善的患者。
研究设计与样本
- 回顾性分析本机构2009年至2014年间所有250例接受首次肝移植的肝硬化患者,评估移植后结局。
- 98例患者在移植前3个月内符合慢加急性肝衰竭诊断标准。
主要发现
- 与非慢加急性肝衰竭患者相比,慢加急性肝衰竭与移植后短期发病率和死亡率显著升高相关(90天患者生存率96.1%非慢加急性肝衰竭 vs 72.4%慢加急性肝衰竭,P<0.0001)。
- 移植前临床改善定义为至少一个先前衰竭器官系统恢复,见于98例慢加急性肝衰竭患者中的37例,多发生于诊断后数日内。
- 移植前临床改善与良好的移植后生存率相关,接近非慢加急性肝衰竭移植受者。
- 移植后90天以后,慢加急性肝衰竭与非慢加急性肝衰竭移植受者的患者生存率和长期移植物功能在长达5年内相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute-on-chronic liver failure (ACLF) is a severe complication of liver cirrhosis associated with excess short-term mortality rates. Orthotopic liver transplantation (OLT) is a potentially life-saving therapeutic modality for acute-on-chronic liver failure patients, but selection of transplant candidates with an acceptable post-transplant outcome is difficult. AIM: To assess the risk of liver transplantation in patients with ACLF, and to determine parameters that predict post-transplant survival in this patient cohort. METHODS: We retrospectively analysed all 250 patients with cirrhosis who underwent their first liver transplantation between 2009 and 2014 at our institution, and assessed post-transplant outcomes. RESULTS: Of 250 cirrhotic liver transplant recipients, 98 patients fulfilled the diagnostic criteria for acute-on-chronic liver failure in the 3-month pre-transplant period. Compared to non-ACLF patients, ACLF was associated with significantly higher short-term morbidity and mortality after liver transplantation (90-day patient survival 96.1% non-ACLF vs 72.4% ACLF patients, P < 0.0001). Clinical improvement in the pre-transplant period, as defined by recovery of at least one previously failed organ system, was observed in 37 of 98 acute-on-chronic liver failure patients, mostly within several days after diagnosis. Most notably, clinical improvement prior to liver transplantation was associated with excellent post-transplant survival rates that approximated non-ACLF transplant recipients. Following the 90-day post-transplant period, patient survival and long-term graft functions were comparable between ACLF and non-ACLF liver transplant recipients for up to 5 years. CONCLUSIONS: Acute-on-chronic liver failure predicts adverse outcome after orthotopic liver transplantation. Given the dismal prognosis without transplantation, however, our results indicate that ACLF patients can be transplanted with comparably good outcomes, in particular patients who improve under conservative therapeutic measures.
引用
- Huebener P, Sterneck MR, Bangert K, et al. Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival. Aliment Pharmacol Ther. 2018. PMID: 29611203. doi:10.1111/apt.14627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。